ATE260910T1 - 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) - Google Patents
4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep)Info
- Publication number
- ATE260910T1 ATE260910T1 AT98948919T AT98948919T ATE260910T1 AT E260910 T1 ATE260910 T1 AT E260910T1 AT 98948919 T AT98948919 T AT 98948919T AT 98948919 T AT98948919 T AT 98948919T AT E260910 T1 ATE260910 T1 AT E260910T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrocinolines
- ctep
- heteroaryl
- inhibitors
- transfer protein
- Prior art date
Links
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 title 2
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 title 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 208000032928 Dyslipidaemia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19741051A DE19741051A1 (de) | 1997-09-18 | 1997-09-18 | Hetero-Tetrahydrochinoline |
| PCT/EP1998/005656 WO1999014215A1 (de) | 1997-09-18 | 1998-09-07 | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester-transfer-proteins (ctep) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE260910T1 true ATE260910T1 (de) | 2004-03-15 |
Family
ID=7842737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98948919T ATE260910T1 (de) | 1997-09-18 | 1998-09-07 | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US6387929B1 (https=) |
| EP (1) | EP1017692B1 (https=) |
| JP (1) | JP2001516757A (https=) |
| AT (1) | ATE260910T1 (https=) |
| AU (1) | AU9536898A (https=) |
| DE (2) | DE19741051A1 (https=) |
| DK (1) | DK1017692T3 (https=) |
| ES (1) | ES2216316T3 (https=) |
| HN (1) | HN1998000143A (https=) |
| PT (1) | PT1017692E (https=) |
| WO (1) | WO1999014215A1 (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| DE19741051A1 (de) * | 1997-09-18 | 1999-03-25 | Bayer Ag | Hetero-Tetrahydrochinoline |
| WO2000038721A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| JP2004534812A (ja) | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | 薬物および中性ポリマーの分散物の医薬組成物 |
| OA12625A (en) | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug. |
| DE10148436A1 (de) * | 2001-10-01 | 2003-04-17 | Bayer Ag | Tetrahydrochinoline |
| US6817530B2 (en) | 2001-12-18 | 2004-11-16 | Digimarc Id Systems | Multiple image security features for identification documents and methods of making same |
| IL162533A0 (en) | 2001-12-19 | 2005-11-20 | Atherogenics Inc | Chalcone derivatives and their use to treat diseases |
| WO2003053359A2 (en) | 2001-12-19 | 2003-07-03 | Atherogenics, Inc. | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| US7728048B2 (en) | 2002-12-20 | 2010-06-01 | L-1 Secure Credentialing, Inc. | Increasing thermal conductivity of host polymer used with laser engraving methods and compositions |
| US6852753B2 (en) | 2002-01-17 | 2005-02-08 | Pharmacia Corporation | Alkyl/aryl hydroxy or keto thiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| DE60320940D1 (de) | 2002-02-01 | 2008-06-26 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| US7824029B2 (en) | 2002-05-10 | 2010-11-02 | L-1 Secure Credentialing, Inc. | Identification card printer-assembler for over the counter card issuing |
| JP2006513186A (ja) | 2002-12-20 | 2006-04-20 | ファイザー・プロダクツ・インク | Ｃｅｔｐ阻害剤およびｈｍｇ−ｃｏａレダクターゼ阻害剤を含む剤形 |
| PT1603553E (pt) | 2003-03-17 | 2012-02-03 | Japan Tobacco Inc | Composições farmacêuticas de inibidores de cetp |
| DE602004030434D1 (de) | 2003-04-16 | 2011-01-20 | L 1 Secure Credentialing Inc | Dreidimensionale datenspeicherung |
| TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合 |
| CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| BRPI0413277A (pt) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas |
| MXPA06003357A (es) * | 2003-09-26 | 2006-06-08 | Japan Tobacco Inc | Metodo para inhibir la produccion de lipoproteina remanente. |
| EP1720893B1 (en) * | 2004-02-26 | 2014-08-13 | Baylor Research Institute | Compositions and methods for the systemic treatment of arthritis |
| US8127137B2 (en) | 2004-03-18 | 2012-02-28 | Digimarc Corporation | Watermark payload encryption for media including multiple watermarks |
| US20060116369A1 (en) * | 2004-10-25 | 2006-06-01 | Shyamlal Ramchandani | Certain compounds, compositions, and methods |
| WO2006065842A2 (en) * | 2004-12-13 | 2006-06-22 | Synta Pharmaceuticals Corp. | 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof |
| ES2384980T3 (es) * | 2004-12-18 | 2012-07-16 | Bayer Pharma Aktiengesellschaft | Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos |
| BRPI0519566A2 (pt) * | 2004-12-18 | 2009-01-27 | Bayer Healthcare Ag | derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| WO2006098394A1 (ja) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | 脂質吸収抑制方法および脂質吸収抑制剤 |
| US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
| JP2009512715A (ja) | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | レニン阻害剤と抗異脂肪血症剤および／または抗肥満症剤の組み合わせ |
| DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
| BRPI0909105A2 (pt) * | 2008-03-05 | 2015-08-25 | Boehringer Ingelheim Int | Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica |
| EP2379547A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
| US20110243940A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Bicyclic pyranone derivatives and methods of use thereof |
| UY33229A (es) | 2010-02-19 | 2011-09-30 | Boehringer Ingelheim Int | Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación |
| CA2804924C (en) * | 2010-07-09 | 2016-06-28 | Daiichi Sankyo Company, Limited | Substituted pyridine compound |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| EP2760868B1 (en) | 2011-08-17 | 2018-04-25 | Boehringer Ingelheim International GmbH | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| TWI570118B (zh) * | 2012-01-06 | 2017-02-11 | 第一三共股份有限公司 | 經取代之吡啶化合物的酸加成鹽 |
| US20230227410A1 (en) * | 2022-01-17 | 2023-07-20 | King Abdulaziz University | Tetrahydroquinoline derivatives and a process of preparation thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| CA1336714C (en) * | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis |
| DE68918713T2 (de) | 1988-01-18 | 1995-03-16 | Toshiba Kawasaki Kk | Interne Pumpe für Kernreaktor. |
| NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
| DE19627431A1 (de) | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
| DE19709125A1 (de) | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
| DE19741051A1 (de) * | 1997-09-18 | 1999-03-25 | Bayer Ag | Hetero-Tetrahydrochinoline |
-
1997
- 1997-09-18 DE DE19741051A patent/DE19741051A1/de not_active Withdrawn
-
1998
- 1998-09-07 JP JP2000511764A patent/JP2001516757A/ja active Pending
- 1998-09-07 DK DK98948919T patent/DK1017692T3/da active
- 1998-09-07 AT AT98948919T patent/ATE260910T1/de not_active IP Right Cessation
- 1998-09-07 EP EP98948919A patent/EP1017692B1/de not_active Expired - Lifetime
- 1998-09-07 DE DE59810922T patent/DE59810922D1/de not_active Expired - Fee Related
- 1998-09-07 PT PT98948919T patent/PT1017692E/pt unknown
- 1998-09-07 WO PCT/EP1998/005656 patent/WO1999014215A1/de not_active Ceased
- 1998-09-07 AU AU95368/98A patent/AU9536898A/en not_active Abandoned
- 1998-09-07 ES ES98948919T patent/ES2216316T3/es not_active Expired - Lifetime
- 1998-09-07 US US09/508,399 patent/US6387929B1/en not_active Expired - Fee Related
- 1998-09-18 HN HN1998000143A patent/HN1998000143A/es unknown
-
2001
- 2001-10-31 US US09/999,233 patent/US6958346B2/en not_active Expired - Fee Related
-
2005
- 2005-10-25 US US11/257,931 patent/US7192971B2/en not_active Expired - Fee Related
-
2007
- 2007-02-22 US US11/677,790 patent/US20070142420A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6387929B1 (en) | 2002-05-14 |
| PT1017692E (pt) | 2004-06-30 |
| DK1017692T3 (da) | 2004-07-12 |
| US6958346B2 (en) | 2005-10-25 |
| EP1017692A1 (de) | 2000-07-12 |
| WO1999014215A1 (de) | 1999-03-25 |
| US20020062024A1 (en) | 2002-05-23 |
| DE19741051A1 (de) | 1999-03-25 |
| US20070142420A1 (en) | 2007-06-21 |
| DE59810922D1 (de) | 2004-04-08 |
| US7192971B2 (en) | 2007-03-20 |
| ES2216316T3 (es) | 2004-10-16 |
| HN1998000143A (es) | 1999-04-09 |
| JP2001516757A (ja) | 2001-10-02 |
| US20060069112A1 (en) | 2006-03-30 |
| AU9536898A (en) | 1999-04-05 |
| EP1017692B1 (de) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE260910T1 (de) | 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep) | |
| WO1999002497A3 (en) | Pyridine derivatives | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| ATE301122T1 (de) | Kernerweiterte perylenbisimide und ihre verwendung als fluoreszenzfarbstoffe | |
| TR199902626T2 (xx) | Enflamasyon tedavisi i�in ikameli benzopiran t�revleri. | |
| BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
| BR0010220A (pt) | Compostos de pirimidinona | |
| ATE421954T1 (de) | Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor | |
| DE69534300D1 (de) | Neues multimerisierendes reagenz | |
| DE69928952D1 (de) | Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe | |
| ATE230394T1 (de) | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen | |
| TR199802385T2 (xx) | TNF inhibit�rleri ve FDE-IV inhibit�rleri olarak kinolin karboksamidler. | |
| FI942049A0 (fi) | Bentsofuranyyli- ja tiofenyylialkaanikarboksyylihappojohdannaisia | |
| NO20003600D0 (no) | Kaliumkanal inhibitorer | |
| DE69725153D1 (de) | Kaliumkanal-blocker | |
| DE69529849D1 (de) | Biphenyl-2-carbonsäure-tetrahydro-isochinolin-6-yl amid derivate, deren hestellung und deren verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und/oder der apolipoprotein b (apo b) sekretion | |
| DE69928697D1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
| DE69728869D1 (de) | Von aminosauren und hydroxysauren substituierte benzamidinderivate und deren verwendung als antikoagulantien | |
| DE69609864D1 (de) | Steroidnitritesterderivate und ihre verwendung als entzündungshemmende medikamente | |
| NO20010956L (no) | Modulering av hukommelseseffektor T-celler samt midler for dette | |
| ATE253059T1 (de) | Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer | |
| DE69414194D1 (de) | Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren | |
| BRPI0415034A (pt) | derivados de aminopiridina como inibidores de não-sintase induzìveis | |
| DK1015437T3 (da) | Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |